Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocco Totaro

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Journal of Translational Medicine|November 15, 2012
A gender-related action of IFNbeta-therapy was found in multiple sclerosisIda Contasta, Rocco Totaro, Patrizia Pellegrini, et al.
Clinical Neuropharmacology|December 23, 2004
IFNbeta-1a treatment and reestablishment of Th1 regulation in MS patients: dose effectsPatrizia Pellegrini, Rocco Totaro, Ida Contasta, et al.
Stroke|May 10, 2005
Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based studyCarmine Marini, Federica De Santis, Simona Sacco, et al.
Frontiers in Neurology|July 17, 2024
Network analysis of negative emotions in patients with episodic migraine: need for a multidisciplinary perspectiveFederica Guerra, Dina Di Giacomo, Jessica Ranieri, et al.
Functional Neurology|July 6, 2017
Object decision and multiple sclerosis: a preliminary studyN Caputi, A Matrella, Rocco Totaro, et al.
Neuroimmunomodulation|March 10, 2005
Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapyAnna Maria Berghella, Rocco Totaro, Patrizia Pellegrini, et al.
The Neuroradiology Journal|August 18, 2016
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosisLucia Patriarca, Silvia Torlone, Fabiana Ferrari, et al.
The Journal of Dermatological Treatment|April 20, 2018
Interferon-beta injection site reactions in patients with multiple sclerosisMartina Maurelli, Roberto Bergamaschi, Ambra Antonini, et al.
Frontiers in Neurology|March 20, 2026
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosisPietro Annovazzi, Marinella Clerico, Eleonora Cocco, et al.
Frontiers in Neurology|May 14, 2026
Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosisPietro Annovazzi, Marinella Clerico, Eleonora Cocco, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Journal of Translational Medicine|November 15, 2012
A gender-related action of IFNbeta-therapy was found in multiple sclerosisIda Contasta, Rocco Totaro, Patrizia Pellegrini, et al.
Clinical Neuropharmacology|December 23, 2004
IFNbeta-1a treatment and reestablishment of Th1 regulation in MS patients: dose effectsPatrizia Pellegrini, Rocco Totaro, Ida Contasta, et al.
Stroke|May 10, 2005
Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based studyCarmine Marini, Federica De Santis, Simona Sacco, et al.
Frontiers in Neurology|July 17, 2024
Network analysis of negative emotions in patients with episodic migraine: need for a multidisciplinary perspectiveFederica Guerra, Dina Di Giacomo, Jessica Ranieri, et al.
Functional Neurology|July 6, 2017
Object decision and multiple sclerosis: a preliminary studyN Caputi, A Matrella, Rocco Totaro, et al.
Neuroimmunomodulation|March 10, 2005
Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapyAnna Maria Berghella, Rocco Totaro, Patrizia Pellegrini, et al.
The Neuroradiology Journal|August 18, 2016
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosisLucia Patriarca, Silvia Torlone, Fabiana Ferrari, et al.
The Journal of Dermatological Treatment|April 20, 2018
Interferon-beta injection site reactions in patients with multiple sclerosisMartina Maurelli, Roberto Bergamaschi, Ambra Antonini, et al.
Frontiers in Neurology|March 20, 2026
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosisPietro Annovazzi, Marinella Clerico, Eleonora Cocco, et al.
Frontiers in Neurology|May 14, 2026
Correction: Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosisPietro Annovazzi, Marinella Clerico, Eleonora Cocco, et al.
Pageof 7